^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MB-106

    i
    Company:
    Fortress, Fred Hutchinson Cancer Center
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs: